IL1A and atrial fibrillation: Interleukin 1 treatment (IL-1α and IL-1β) of the four cell types/origins (degenerate and non-degenerate cells, from AF or NP) resulted in altered in expression of genes for matrix molecules and matrix-degrading enzymes.